Vilon — Vendor Pricing & Purity Guide
Research Overview
Vilon is a synthetic dipeptide (Lys-Glu) bioregulator developed by Dr. Khavinson targeting the immune system. Despite being one of the shortest bioactive peptides studied (only 2 amino acids), it has demonstrated immunomodulatory effects by promoting T-cell differentiation and restoring age-related immune decline.
Vilon is notable for its extreme simplicity — as a dipeptide, it is highly stable, resistant to proteolytic degradation, and potentially orally bioavailable. It is part of Khavinson's immunomodulatory peptide cluster alongside Thymalin.
Key Research Findings
- •Promoted T-cell differentiation despite being only 2 amino acids
- •Restored immune parameters in aged animal models
- •Extremely stable due to dipeptide structure — resistant to proteolytic degradation
- •Potentially orally bioavailable due to small size
Research Dosage Protocols
Administered in 10-day courses via intramuscular injection or sublingual administration, repeated 2-3 times annually.
For research reference only. Not medical advice. Not for human consumption.
Price Comparison (6 products from 6 vendors)
| Vendor | Price | Stock |
|---|---|---|
| Biotech Peptides | $61.00 $3.05/mg 20mg vial | In Stock |
| Swiss Chems | $63.00 $3.15/mg 20mg vial | In Stock |
| Peptide Sciences | $65.00 $3.25/mg 20mg lyophilized | In Stock |
| Core Peptides | $74.00 $3.70/mg 20mg vial | In Stock |
| BioLongevity Labs | $79.97 $4.00/mg 20mg vial | In Stock |
| Soma Chems | $64.99 vial | In Stock |
Frequently Asked Questions
What is Vilon?
Vilon is the smallest known bioactive immunomodulatory peptide (2 amino acids). It promotes T-cell differentiation and is part of Khavinson's immune-targeting bioregulatory system.